Rv1908c - p.Ala130Thr
Drug resistance types
0 Sensitive
2 RR-TB
0 HR-TB
13 MDR-TB
2 Pre-XDR-TB
0 XDR-TB
0 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.2.1 | 11 |
| lineage4.8 | 2 |
| lineage2.2.1.1;lineage4.1.2 | 1 |
| lineage2.2.1.1 | 2 |
| lineage2.2.1;lineage3 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 17 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Variant Proportion
Hover over a Country 0–0.1
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 |
|---|---|---|---|
| SRR16157043 | MDR-TB | lineage2.2.1 | None |
| ERR13284458 | MDR-TB | lineage4.8 | None |
| SRR16156826 | MDR-TB | lineage2.2.1 | None |
| SRR10869218 | Pre-XDR-TB | lineage2.2.1 | None |
| SRR16156679 | MDR-TB | lineage2.2.1 | None |
| SRR16156720 | MDR-TB | lineage2.2.1 | None |
| ERR11081345 | MDR-TB | lineage4.8 | None |
| SRR16156843 | MDR-TB | lineage2.2.1 | None |
| SRR16156852 | MDR-TB | lineage2.2.1 | None |
| ERR10748565 | MDR-TB | lineage2.2.1.1;lineage4.1.2 | None |
| SRR21576601 | RR-TB | lineage2.2.1 | None |
| SRR30180279 | MDR-TB | lineage2.2.1.1 | None |
| SRR3105742 | Pre-XDR-TB | lineage2.2.1;lineage3 | None |
| SRR21747005 | MDR-TB | lineage2.2.1.1 | None |
| SRR16156837 | MDR-TB | lineage2.2.1 | None |
| SRR21576646 | RR-TB | lineage2.2.1 | None |
| SRR16156825 | MDR-TB | lineage2.2.1 | None |
